These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 19089921)
41. 15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells. Shureiqi I; Chen D; Lee JJ; Yang P; Newman RA; Brenner DE; Lotan R; Fischer SM; Lippman SM J Natl Cancer Inst; 2000 Jul; 92(14):1136-42. PubMed ID: 10904086 [TBL] [Abstract][Full Text] [Related]
42. Overexpression of platelet-type 12-lipoxygenase promotes tumor cell survival by enhancing alpha(v)beta(3) and alpha(v)beta(5) integrin expression. Pidgeon GP; Tang K; Cai YL; Piasentin E; Honn KV Cancer Res; 2003 Jul; 63(14):4258-67. PubMed ID: 12874035 [TBL] [Abstract][Full Text] [Related]
43. Monocyte chemoattractant protein-1 modulates invasion and apoptosis of PC-3M prostate cancer cells via regulating expression of VEGF, MMP9 and caspase-3. Shi CL; Yu CH; Zhang Y; Zhao D; Chang XH; Wang WH Asian Pac J Cancer Prev; 2011; 12(2):555-9. PubMed ID: 21545229 [TBL] [Abstract][Full Text] [Related]
44. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice. Zhang F; Lee J; Lu S; Pettaway CA; Dong Z Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637 [TBL] [Abstract][Full Text] [Related]
45. Zyflamend-mediated inhibition of human prostate cancer PC3 cell proliferation: effects on 12-LOX and Rb protein phosphorylation. Yang P; Cartwright C; Chan D; Vijjeswarapu M; Ding J; Newman RA Cancer Biol Ther; 2007 Feb; 6(2):228-36. PubMed ID: 17218785 [TBL] [Abstract][Full Text] [Related]
46. The methyltransferase inhibitor 5-aza-2-deoxycytidine induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells. Hsi LC; Xi X; Wu Y; Lippman SM Mol Cancer Ther; 2005 Nov; 4(11):1740-6. PubMed ID: 16275995 [TBL] [Abstract][Full Text] [Related]
47. Therapeutic molecular targeting of 15-lipoxygenase-1 in colon cancer. Wu Y; Fang B; Yang XQ; Wang L; Chen D; Krasnykh V; Carter BZ; Morris JS; Shureiqi I Mol Ther; 2008 May; 16(5):886-92. PubMed ID: 18388920 [TBL] [Abstract][Full Text] [Related]
48. Overexpression of 15-lipoxygenase-1 induces growth arrest through phosphorylation of p53 in human colorectal cancer cells. Kim JS; Baek SJ; Bottone FG; Sali T; Eling TE Mol Cancer Res; 2005 Sep; 3(9):511-7. PubMed ID: 16179498 [TBL] [Abstract][Full Text] [Related]
49. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes. Shukla S; Gupta S Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058 [TBL] [Abstract][Full Text] [Related]
50. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo. Liu XH; Kirschenbaum A; Yao S; Lee R; Holland JF; Levine AC J Urol; 2000 Sep; 164(3 Pt 1):820-5. PubMed ID: 10953162 [TBL] [Abstract][Full Text] [Related]
51. The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cells. Shureiqi I; Jiang W; Zuo X; Wu Y; Stimmel JB; Leesnitzer LM; Morris JS; Fan HZ; Fischer SM; Lippman SM Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9968-73. PubMed ID: 12909723 [TBL] [Abstract][Full Text] [Related]
52. Overexpression of 12/15-lipoxygenase, an ortholog of human 15-lipoxygenase-1, in the prostate tumors of TRAMP mice. Kelavkar UP; Glasgow W; Olson SJ; Foster BA; Shappell SB Neoplasia; 2004; 6(6):821-30. PubMed ID: 15720809 [TBL] [Abstract][Full Text] [Related]
53. 8-Geranyloxycarbostyril as a potent 15-LOX-1 inhibitor showed great anti-tumor effects against prostate cancer. Aghasizadeh M; Moghaddam T; Bahrami AR; Sadeghian H; Alavi SJ; Matin MM Life Sci; 2022 Mar; 293():120272. PubMed ID: 35065164 [TBL] [Abstract][Full Text] [Related]
54. Platelet-type 12-lipoxygenase activates NF-kappaB in prostate cancer cells. Kandouz M; Nie D; Pidgeon GP; Krishnamoorthy S; Maddipati KR; Honn KV Prostaglandins Other Lipid Mediat; 2003 Jul; 71(3-4):189-204. PubMed ID: 14518561 [TBL] [Abstract][Full Text] [Related]
55. Concordant induction of 15-lipoxygenase-1 and mutant p53 expression in human prostate adenocarcinoma: correlation with Gleason staging. Kelavkar UP; Cohen C; Kamitani H; Eling TE; Badr KF Carcinogenesis; 2000 Oct; 21(10):1777-87. PubMed ID: 11023533 [TBL] [Abstract][Full Text] [Related]
56. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Inoue K; Slaton JW; Eve BY; Kim SJ; Perrotte P; Balbay MD; Yano S; Bar-Eli M; Radinsky R; Pettaway CA; Dinney CP Clin Cancer Res; 2000 May; 6(5):2104-19. PubMed ID: 10815938 [TBL] [Abstract][Full Text] [Related]
57. Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cells. Tang S; Bhatia B; Maldonado CJ; Yang P; Newman RA; Liu J; Chandra D; Traag J; Klein RD; Fischer SM; Chopra D; Shen J; Zhau HE; Chung LW; Tang DG J Biol Chem; 2002 May; 277(18):16189-201. PubMed ID: 11839751 [TBL] [Abstract][Full Text] [Related]
58. 15-Lipoxygenase-1 suppression of colitis-associated colon cancer through inhibition of the IL-6/STAT3 signaling pathway. Mao F; Xu M; Zuo X; Yu J; Xu W; Moussalli MJ; Elias E; Li HS; Watowich SS; Shureiqi I FASEB J; 2015 Jun; 29(6):2359-70. PubMed ID: 25713055 [TBL] [Abstract][Full Text] [Related]
59. Novel Poly(Adenosine Diphosphate-Ribose) Polymerase (PARP) Inhibitor, AZD2461, Down-Regulates VEGF and Induces Apoptosis in Prostate Cancer Cells. Sargazi S; Saravani R; Zavar Reza J; Zarei Jaliani H; Galavi H; Moudi M; Abtahi NA Iran Biomed J; 2019 Sep; 23(5):312-23. PubMed ID: 31102368 [TBL] [Abstract][Full Text] [Related]
60. Lipoxygenase inhibitors attenuate growth of human pancreatic cancer xenografts and induce apoptosis through the mitochondrial pathway. Tong WG; Ding XZ; Witt RC; Adrian TE Mol Cancer Ther; 2002 Sep; 1(11):929-35. PubMed ID: 12481414 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]